REBECCA CONLEY: Open Payments
NPI 1811231772 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,529 in 146 payments from 36 companies in 2025. Trend: 2023 $387 · 2024 $2,240 · 2025 $2,529
Food & beverage: $2,529
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $322 |
| Janssen Biotech, Inc. | 17 | $211 |
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| Daiichi Sankyo Inc. | 10 | $183 |
| Ipsen Biopharmaceuticals, Inc | 9 | $175 |
| Celgene Corporation | 7 | $137 |
| Merck Sharp & Dohme LLC | 7 | $127 |
| PFIZER INC. | 8 | $124 |
| Regeneron Healthcare Solutions, Inc. | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
Products named: Onivyde, REBLOZYL, KEYTRUDA, LIBTAYO, Enhertu, KISQALI, ERLEADA, PLUVICTO.
Industry payments across KY — which companies pay providers there.
